Countries China

Antengene's XPOVIO® Approved in Hong Kong for Relapsed Multiple Myeloma

XPOVIO® has received regulatory approvals in 41 countries and regions including the United States, Israel, the United Kingdo...

 July 17, 2023 | News

Chinese Scientists Extract 'Red Marrow Peptide' from Young Yaks, Promising Breakthrough for Cardiovascular Health

As an important hematopoietic and metabolic immune organ of human body, red blood marrow is known as the systematic "soldier factory". Red blood marrow is ...

 July 17, 2023 | News

Harbour BioMed's 2023 Interim Results: Positive Profit Alert Driven by Innovation

  Based on the preliminary review of the Company's unaudited management accounts for the six months ended June 30, 2023, the total revenue is ex...

 July 14, 2023 | News

Kedrion's global portfolio expands to China to supply human Albumin

Kedrion joined forces with BPL in 2022 This is the first ever approval for a BPL product in China The China Albumin market is the world's largest ...

 July 13, 2023 | News

China-Singapore Translational Medicine Center Advances CGT Industry Leadership

26th Jun 2023, the 13th Singapore Guangdong Collaboration Council was held in Singapore. During the event, leaders from both Governments wit...

 July 12, 2023 | News

RGE Builds China's Largest Oleochemical Industry Integration Facility

The commissioning ceremony was attended by Belinda Tanoto, Managing Director of RGE China; Wang Minyan, Chairman of the China Cleaning Industry Associ...

 July 12, 2023 | News

Doer Biologics Announces License Agreement with BioNTech

Under the terms of the agreement, Doer Bio will grant BioNTech a worldwide license to utilize one of Doer Bio's innovative discoveries to research, develop...

 July 12, 2023 | News

Broncus Completes First Registered Clinical Trials of Targeted Lung Denervation System

The multi-center clinical randomized controlled trial on the ''treatment of Chronic Obstructive Pulmonary Disease (''COPD'') by targeted lung denervation a...

 July 11, 2023 | News

HOYA Group PENTAX Medical Established Manufacturing, R & D and Service Center in China

The manufacturing site is going to produce PENTAX Medical endoscopic solutions for China. A state-of-the-art service center is to enhance customer ex...

 July 11, 2023 | News

RemeGen and Innovent Collaborate on Clinical Trials for Advanced Solid Tumors

RemeGen Co., Ltd. ("RemeGen" or "the Company") (HKG: 9995, SHA: 688331), a fully-integrated commercial-stage biotechnology company, announce...

 July 10, 2023 | News

280 Bio receives IND approval from the FDA for YL-17231

80Bio, Inc. a clinical stage biotechnology company focused on the development of precision oncology medicines, today announced that the U.S. Food and Drug ...

 July 10, 2023 | News

Transcenta Receives Approvals for Global Phase III Trial of Osemitamab (TST001)

To initiate TranStar 301 global Phase III pivotal trial of Osemitamab (TST001) in combination with Nivolumab and chemotherapy for the first-line treatment ...

 July 10, 2023 | News

Hexvix® Completes Phase III Bridging Trial Enrollment for Bladder Cancer

The study is a prospective, self-controlled, multicenter Phase Ⅲ trial aimed at investigating the additional detection rate and safety of Hexvix®&nbs...

 July 10, 2023 | News

GeneQuantum Healthcare and Aimed Bio collaborate to develop 5 innovative ADC drugs

Since April of last year, GeneQuantum and Aimed Bio have been collaborating on the joint development of a FGFR3-targeting ADC named GQ1011/AMB302. The prog...

 July 07, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close